Management of Acute Asthma in the Emergency Department

Total Page:16

File Type:pdf, Size:1020Kb

Management of Acute Asthma in the Emergency Department June 2013 Management Of Acute Asthma Volume 15, Number 6 In The Emergency Department Authors Steven G. Schauer, DO Staff Physician, Bayne-Jones Army Community Hospital, Fort Polk, LA Abstract Peter J. Cuenca, MD Staff Physician, San Antonio Military Medical Center, San Antonio, TX Jeremiah J. Johnson, MD Asthma is primarily a clinical diagnosis that is made from a Staff Physician, San Antonio Military Medical Center, San Antonio, TX combination of historical features and clinical examination find- Sasha Ramirez, DO ings. The mainstay of asthma treatment includes short-acting beta Resident Physician, San Antonio Military Medical Center, San Antonio, TX agonist therapy (albuterol) and steroids. Handheld inhalers are Peer Reviewers sufficient for most inhaled therapy; all patients on inhalers should Syed Ali, MD, MS be provided with a spacer. The severity of asthma exacerbations is Assistant Professor of Medicine, Section of Emergency Medicine, Baylor determined by 3 features: (1) clinical presentation, (2) peak expira- College of Medicine, Houston, TX tory flow rates, and (3) vital signs. Additional testing, such as chest Scott D. Weingart, MD, FCCM Associate Professor of Emergency Medicine, Director, Division of ED x-ray and blood gas measurements, is reserved for select patients. Critical Care, Icahn School of Medicine at Mount Sinai, New York, NY Spirometry aids in the diagnosis of asthma and measurement Susan R. Wilcox, MD of severity, but it is not always required, nor should it be solely Former Attending Physician in Emergency Medicine/Surgical ICU, Massachusetts General Hospital; currently Anesthesiology Resident, relied upon to make disposition decisions. Inhaled ipratropium Massachusetts General Hospital, Boston, MA decreases hospitalization rates, and it should be routinely used. Levalbuterol provides little to no advantage over less-expensive CME Objectives racemic albuterol. Noninvasive positive pressure ventilation may Upon completion of this article, you should be able to: be utilized in patients with moderate to severe exacerbations. 1. Identify and distinguish key features of mild to severe asthma and triage patients based on initial history and physical examination. Ketamine may be considered in severe exacerbations, but it should 2. Formulate a broad differential diagnosis of new-onset asthma not be used routinely. Magnesium sulfate may be beneficial in based on a patient’s age and comorbidities. severe asthma exacerbations, but routine use for mild to moderate 3. Describe the underlying pathophysiology of asthma and the basic exacerbations is not indicated. treatment options that are critical in the management of asthma. Editor-In-Chief Nicholas Genes, MD, PhD Keith A. Marill, MD Stephen H. Thomas, MD, MPH Research Editor Andy Jagoda, MD, FACEP Assistant Professor, Department of Assistant Professor, Harvard Medical George Kaiser Family Foundation Michael Guthrie, MD Professor and Chair, Department of Emergency Medicine, Icahn School School; Emergency Department Professor & Chair, Department of Emergency Medicine Residency, Emergency Medicine, Icahn School of Medicine at Mount Sinai, New Attending Physician, Massachusetts Emergency Medicine, University of Icahn School of Medicine at Mount of Medicine at Mount Sinai, Medical York, NY General Hospital, Boston, MA Oklahoma School of Community Sinai, New York, NY Medicine, Tulsa, OK Director, Mount Sinai Hospital, New Michael A. Gibbs, MD, FACEP Charles V. Pollack, Jr., MA, MD, York, NY Professor and Chair, Department FACEP Jenny Walker, MD, MPH, MSW International Editors of Emergency Medicine, Carolinas Chairman, Department of Emergency Assistant Professor, Departments of Peter Cameron, MD Associate Editor-In-Chief Medical Center, University of North Medicine, Pennsylvania Hospital, Preventive Medicine, Pediatrics, and Academic Director, The Alfred Kaushal Shah, MD, FACEP Carolina School of Medicine, Chapel University of Pennsylvania Health Medicine Course Director, Mount Emergency and Trauma Centre, Associate Professor, Department of Hill, NC System, Philadelphia, PA Sinai Medical Center, New York, NY Monash University, Melbourne, Emergency Medicine, Icahn School Steven A. Godwin, MD, FACEP Michael S. Radeos, MD, MPH Ron M. Walls, MD Australia of Medicine at Mount Sinai, New Professor and Chair, Department Assistant Professor of Emergency Professor and Chair, Department of York, NY Giorgio Carbone, MD of Emergency Medicine, Assistant Medicine, Weill Medical College Emergency Medicine, Brigham and Chief, Department of Emergency Editorial Board Dean, Simulation Education, of Cornell University, New York; Women’s Hospital, Harvard Medical Medicine Ospedale Gradenigo, University of Florida COM- Research Director, Department of School, Boston, MA William J. Brady, MD Torino, Italy Jacksonville, Jacksonville, FL Emergency Medicine, New York Scott D. Weingart, MD, FCCM Professor of Emergency Medicine Amin Antoine Kazzi, MD, FAAEM Hospital Queens, Flushing, New York Associate Professor of Emergency and Medicine, Chair, Medical Gregory L. Henry, MD, FACEP Associate Professor and Vice Chair, Medicine, Director, Division of Emergency Response Committee, CEO, Medical Practice Risk Robert L. Rogers, MD, FACEP, Department of Emergency Medicine, ED Critical Care, Icahn School of Medical Director, Emergency Assessment, Inc.; Clinical Professor FAAEM, FACP University of California, Irvine; Medicine at Mount Sinai, New York, Management, University of Virginia of Emergency Medicine, University of Assistant Professor of Emergency American University, Beirut, Lebanon Medical Center, Charlottesville, VA Michigan, Ann Arbor, MI Medicine, The University of NY Maryland School of Medicine, Hugo Peralta, MD John M. Howell, MD, FACEP Peter DeBlieux, MD Baltimore, MD Senior Research Editors Chair of Emergency Services, Professor of Clinical Medicine, Clinical Professor of Emergency Hospital Italiano, Buenos Aires, Interim Public Hospital Director Medicine, George Washington Alfred Sacchetti, MD, FACEP James Damilini, PharmD, BCPS Argentina of Emergency Medicine Services, University, Washington, DC; Director Assistant Clinical Professor, Clinical Pharmacist, Emergency Dhanadol Rojanasarntikul, MD Emergency Medicine Director of of Academic Affairs, Best Practices, Department of Emergency Medicine, Room, St. Joseph’s Hospital and Attending Physician, Emergency Faculty and Resident Development, Inc, Inova Fairfax Hospital, Falls Thomas Jefferson University, Medical Center, Phoenix, AZ Medicine, King Chulalongkorn Louisiana State University Health Church, VA Philadelphia, PA Joseph D. Toscano, MD Memorial Hospital, Thai Red Cross, Science Center, New Orleans, LA Shkelzen Hoxhaj, MD, MPH, MBA Scott Silvers, MD, FACEP Chairman, Department of Emergency Thailand; Faculty of Medicine, Francis M. Fesmire, MD, FACEP Chief of Emergency Medicine, Baylor Chair, Department of Emergency Medicine, San Ramon Regional Chulalongkorn University, Thailand Professor and Director of Clinical College of Medicine, Houston, TX Medicine, Mayo Clinic, Jacksonville, FL Medical Center, San Ramon, CA Suzanne Peeters, MD Research, Department of Emergency Eric Legome, MD Corey M. Slovis, MD, FACP, FACEP Emergency Medicine Residency Medicine, UT College of Medicine, Chief of Emergency Medicine, Professor and Chair, Department Director, Haga Hospital, The Hague, Chattanooga; Director of Chest Pain King’s County Hospital; Professor of of Emergency Medicine, Vanderbilt The Netherlands Center, Erlanger Medical Center, Clinical Emergency Medicine, SUNY University Medical Center; Medical Chattanooga, TN Downstate College of Medicine, Director, Nashville Fire Department and Brooklyn, NY International Airport, Nashville, TN Prior to beginning this activity, see the back page for faculty disclosures and CME accreditation information. Case Presentations asthma is reversible either spontaneously or with medication. A 19-year-old college student presents with marked Asthma is defined by its clinical, physiologic, dyspnea and dysphagia. He reports a history of asthma, and pathologic characteristics, with reversible for which he takes albuterol as his only medication. Over wheezing as the most common finding. From a the last 3 days, he has been coughing and wheezing with public health point of view, understanding the increasing severity. Even though he has been using his underlying causes of asthma and its exacerbants is albuterol inhaler every 2 hours, there has been minimal key to preventive strategies. From an emergency to no response. EMS administered a 10-mg albuterol medicine perspective, having clear strategies on how nebulizer treatment and magnesium sulfate intravenously to best manage acute presentations is key to good en route to the ED. Upon arrival, the patient appears in outcomes. This issue of Emergency Medicine Practice extremis, and you wonder if there is something you can do provides an evidence-based review of asthma as to avoid intubation . it relates to emergency department (ED) care and While establishing IV access and calling respira- establishes best-practice approaches to management. tory therapy for your first patient, a 24-year-old Hispanic female with a history of asthma who is 15 weeks pregnant Critical Appraisal Of The Literature presents with tachypnea and acute shortness of breath with audible wheezing. She has been taking albuterol and The Ovid MEDLINE®, CINAHL (Cumulative In- fluticasone at home with no relief of symptoms. She has a dex to Nursing and Allied Health Literature), and blood pressure
Recommended publications
  • Caring for Children with Special Needs ALLERGIES and ASTHMA
    caring for children with special needs ALLERGIES AND ASTHMA We don’t usually think of children with allergies or asthma as children with “special needs,” but they certainly are. In fact, children with these conditions are probably the most frequently encountered “special needs” children. Child care providers can do a great deal to help individual children manage their specific allergy or asthma needs and feel more comfortable in a child care setting. Allergies wastes. Every house has them, no matter how clean. Other inhaled Children with allergies face the allergens include mold, pollen (hay same social difficulties as do adults, fever), animal dander (especially but they have less maturity and from cats), chemicals, and per­ emotional resources to deal with fumes. them. Children find that they cannot eat what their friends eat or The most common allergy symp­ cannot play outside during some toms are seasons. Until a child is mature � a clear, runny nose and enough to understand why she sneezing, cannot do something, you must be � itchy or stuffed-up nose or careful to help the child through the itchy, runny eyes, and difficulties. Start teaching a child early on about what he is allergic to; � asthma (remember that not all you will not always be able to people with asthma have monitor everything. allergies and not all allergies Some foods can cause a life­ cause or develop into asthma). threatening reaction. The mouth, throat, and bronchial tubes swell enough to interfere with breathing. Strategies for inclusion The person may wheeze or faint. Some parents have found that by Often there are generalized hives volunteering to bring food to and/or a swollen face.
    [Show full text]
  • Symptoms Related to Asthma and Chronic Bronchitis in Three Areas of Sweden
    Eur Respir J, 1994, 7, 2146–2153 Copyright ERS Journals Ltd 1994 DOI: 10.1183/09031936.94.07122146 European Respiratory Journal Printed in UK - all rights reserved ISSN 0903 - 1936 Symptoms related to asthma and chronic bronchitis in three areas of Sweden E. Björnsson*, P. Plaschke**, E. Norrman+, C. Janson*, B. Lundbäck+, A. Rosenhall+, N. Lindholm**, L. Rosenhall+, E. Berglund++, G. Boman* Symptoms related to asthma and chronic bronchitis in three areas of Sweden. E. Björnsson, *Dept of Lung Medicine and Asthma P. Plaschke, E. Norrman, C. Janson, B. Lundbäck, A. Rosenhall, N. Lindholm, L. Research Center, Akademiska sjukhu- Rosenhall, E. Berglund, G. Boman. ERS Journals Ltd 1994. set, Uppsala University, Uppsala, Sweden. ABSTRACT: Does the prevalence of respiratory symptoms differ between regions? **Asthma and Allergy Research Center, Sahlgren's Hospital, University of Göteborg, As a part of the European Community Respiratory Health Survey, we present data Göteborg, Sweden. +Dept of Pulmonary from an international questionnaire on asthma symptoms occurring during a 12 Medicine and Allergology, Univer- month period, smoking and symptoms of chronic bronchitis. The questionnaire was sity Hospital of Northern Sweden, Umeå, mailed to 10,800 persons aged 20–44 yrs living in three regions of Sweden (Västerbotten, Sweden. ++Dept of Pulmonary Medicine, Uppsala and Göteborg) with different environmental characteristics. The total Sahlgrenska University Hospital, Göteborg, response rate was 86%. Sweden. Wheezing was reported by 20.5%, and the combination of wheezing without a Correspondence: E. Björnsson, Dept of cold and wheezing with breathlessness by 7.4%. The use of asthma medication was Lung Medicine, Akademiska sjukhuset, S- reported by 5.3%.
    [Show full text]
  • Report of Two Cases Presenting with Acute Abdominal Symptoms
    Journal of Accident and Tension pneumothorax: report of two cases presenting J Accid Emerg Med: first published as 10.1136/emj.11.1.43 on 1 March 1994. Downloaded from Emergency Medicine 1993 with acute abdominal symptoms 10, 43-44 G.W. HOLLINS,1 T. BEATTIE,1 1. HARPER2 & K. LITTLE2 Departments of Accident and Emergency 1 Aberdeen Royal Infirmary, Foresterhill, Aberdeen and 2Royal Infirmary of Edinburgh, Lauriston Place, Edinburgh INTRODUCTION diagnoses were peptic ulcer disease or acute pancreatitis. Work-up appropriate to these diag- Tension pneumothorax constitutes a medical noses was commenced. An erect chest radiograph emergency and rapid diagnosis should be possible revealed a large pneumothorax with mediastinal on the basis of history and clinical examination. shift to the left. Following drainage using a large Following treatment with the delivery of high con- bore needle there was immediate resolution of his centration oxygen and the insertion of a large bore symptoms and all abdominal signs. An intercostal needle into the pleural space of the affected side, chest drain was formally sited and full expansion of the diagnosis can be confirmed radiologically and his right lung was achieved after 36 h. He was dis- an intercostal chest drain formally sited.1'2 We report charged home after 3 days. two cases where diagnosis was not made on the basis of history and examination alone. Both cases Case 2 presented with symptoms and signs suggestive of an acute intra-abdominal pathology and the diag- A 37-year-old male computer operator presented nosis was only made on radiological grounds. with a 1-week history of general malaise associated with mild neck and back pain.
    [Show full text]
  • Emerging Evidence for a Central Epinephrine-Innervated A1- Adrenergic System That Regulates Behavioral Activation and Is Impaired in Depression
    Neuropsychopharmacology (2003) 28, 1387–1399 & 2003 Nature Publishing Group All rights reserved 0893-133X/03 $25.00 www.neuropsychopharmacology.org Perspective Emerging Evidence for a Central Epinephrine-Innervated a1- Adrenergic System that Regulates Behavioral Activation and is Impaired in Depression ,1 1 1 1 1 Eric A Stone* , Yan Lin , Helen Rosengarten , H Kenneth Kramer and David Quartermain 1Departments of Psychiatry and Neurology, New York University School of Medicine, New York, NY, USA Currently, most basic and clinical research on depression is focused on either central serotonergic, noradrenergic, or dopaminergic neurotransmission as affected by various etiological and predisposing factors. Recent evidence suggests that there is another system that consists of a subset of brain a1B-adrenoceptors innervated primarily by brain epinephrine (EPI) that potentially modulates the above three monoamine systems in parallel and plays a critical role in depression. The present review covers the evidence for this system and includes findings that brain a -adrenoceptors are instrumental in behavioral activation, are located near the major monoamine cell groups 1 or target areas, receive EPI as their neurotransmitter, are impaired or inhibited in depressed patients or after stress in animal models, and a are restored by a number of antidepressants. This ‘EPI- 1 system’ may therefore represent a new target system for this disorder. Neuropsychopharmacology (2003) 28, 1387–1399, advance online publication, 18 June 2003; doi:10.1038/sj.npp.1300222 Keywords: a1-adrenoceptors; epinephrine; motor activity; depression; inactivity INTRODUCTION monoaminergic systems. This new system appears to be impaired during stress and depression and thus may Depressive illness is currently believed to result from represent a new target for this disorder.
    [Show full text]
  • Current Management and Outcome of Tracheobronchial Malacia and Stenosis Presenting to the Paediatric Intensive Care Unit
    Intensive Care Med 52001) 27: 722±729 DOI 10.1007/s001340000822 NEONATAL AND PEDIATRIC INTENSIVE CARE David P.Inwald Current management and outcome Derek Roebuck Martin J.Elliott of tracheobronchial malacia and stenosis Quen Mok presenting to the paediatric intensive care unit Abstract Objective: To identify fac- but was not related to any other fac- Received: 10 July 2000 Final Revision received: 14 Oktober 2000 tors associated with mortality and tor. Patients with stenosis required a Accepted: 24 October 2000 prolonged ventilatory requirements significantly longer period of venti- Published online: 16 February 2001 in patients admitted to our paediat- latory support 5median length of Springer-Verlag 2001 ric intensive care unit 5PICU) with ventilation 59 days) than patients tracheobronchial malacia and with malacia 539 days). stenosis diagnosed by dynamic con- Conclusions: Length of ventilation Dr Inwald was supported by the Medical Research Council. This work was jointly trast bronchograms. and bronchographic diagnosis did undertaken in Great Ormond Street Hos- Design: Retrospective review. not predict survival. The only factor pital for Children NHSTrust, which re- Setting: Tertiary paediatric intensive found to contribute significantly to ceived a proportion of its funding from the care unit. mortality was the presence of com- NHSExecutive; the views expressed in this Patients: Forty-eight cases admitted plex cardiac and/or syndromic pa- publication are those of the authors and not to our PICU over a 5-year period in thology. However, patients with necessarily those of the NHSexecutive. whom a diagnosis of tracheobron- stenosis required longer ventilatory chial malacia or stenosis was made support than patients with malacia.
    [Show full text]
  • Acute Gastroenteritis
    Article gastrointestinal disorders Acute Gastroenteritis Deise Granado-Villar, MD, Educational Gap MPH,* Beatriz Cunill-De Sautu, MD,† Andrea In managing acute diarrhea in children, clinicians need to be aware that management Granados, MDx based on “bowel rest” is outdated, and instead reinstitution of an appropriate diet has been associated with decreased stool volume and duration of diarrhea. In general, drug therapy is not indicated in managing diarrhea in children, although zinc supplementation Author Disclosure and probiotic use show promise. Drs Granado-Villar, Cunill-De Sautu, and Objectives After reading this article, readers should be able to: Granados have disclosed no financial 1. Recognize the electrolyte changes associated with isotonic dehydration. relationships relevant 2. Effectively manage a child who has isotonic dehydration. to this article. This 3. Understand the importance of early feedings on the nutritional status of a child who commentary does has gastroenteritis. contain a discussion of 4. Fully understand that antidiarrheal agents are not indicated nor recommended in the an unapproved/ treatment of acute gastroenteritis in children. investigative use of 5. Recognize the role of vomiting in the clinical presentation of acute gastroenteritis. a commercial product/ device. Introduction Acute gastroenteritis is an extremely common illness among infants and children world- wide. According to the Centers for Disease Control and Prevention (CDC), acute diarrhea among children in the United States accounts for more than 1.5 million outpatient visits, 200,000 hospitalizations, and approximately 300 deaths per year. In developing countries, diarrhea is a common cause of mortality among children younger than age 5 years, with an estimated 2 million deaths each year.
    [Show full text]
  • Respiratory Syncytial Virus Bronchiolitis in Children DUSTIN K
    Respiratory Syncytial Virus Bronchiolitis in Children DUSTIN K. SMITH, DO; SAJEEWANE SEALES, MD, MPH; and CAROL BUDZIK, MD Naval Hospital Jacksonville, Jacksonville, Florida Bronchiolitis is a common lower respiratory tract infection in infants and young children, and respiratory syncytial virus (RSV) is the most common cause of this infection. RSV is transmitted through contact with respiratory droplets either directly from an infected person or self-inoculation by contaminated secretions on surfaces. Patients with RSV bronchiolitis usually present with two to four days of upper respiratory tract symptoms such as fever, rhinorrhea, and congestion, followed by lower respiratory tract symptoms such as increasing cough, wheezing, and increased respira- tory effort. In 2014, the American Academy of Pediatrics updated its clinical practice guideline for diagnosis and man- agement of RSV bronchiolitis to minimize unnecessary diagnostic testing and interventions. Bronchiolitis remains a clinical diagnosis, and diagnostic testing is not routinely recommended. Treatment of RSV infection is mainly sup- portive, and modalities such as bronchodilators, epinephrine, corticosteroids, hypertonic saline, and antibiotics are generally not useful. Evidence supports using supplemental oxygen to maintain adequate oxygen saturation; however, continuous pulse oximetry is no longer required. The other mainstay of therapy is intravenous or nasogastric admin- istration of fluids for infants who cannot maintain their hydration status with oral fluid intake. Educating parents on reducing the risk of infection is one of the most important things a physician can do to help prevent RSV infection, especially early in life. Children at risk of severe lower respiratory tract infection should receive immunoprophy- laxis with palivizumab, a humanized monoclonal antibody, in up to five monthly doses.
    [Show full text]
  • Allergic Bronchopulmonary Aspergillosis As a Cause of Bronchial Asthma in Children
    Egypt J Pediatr Allergy Immunol 2012;10(2):95-100. Original article Allergic bronchopulmonary aspergillosis as a cause of bronchial asthma in children Background: Allergic bronchopulmonary aspergillosis (ABPA) occurs in Dina Shokry, patients with asthma and cystic fibrosis. When aspergillus fumigatus spores Ashgan A. are inhaled they grow in bronchial mucous as hyphae. It occurs in non Alghobashy, immunocompromised patients and belongs to the hypersensitivity disorders Heba H. Gawish*, induced by Aspergillus. Objective: To diagnose cases of allergic bronchopulmonary aspergillosis among asthmatic children and define the Manal M. El-Gerby* association between the clinical and laboratory findings of aspergillus fumigatus (AF) and bronchial asthma. Methods: Eighty asthmatic children were recruited in this study and divided into 50 atopic and 30 non-atopic Departments of children. The following were done: skin prick test for aspergillus fumigatus Pediatrics and and other allergens, measurement of serum total IgE, specific serum Clinical Pathology*, aspergillus fumigatus antibody titer IgG and IgE (AF specific IgG and IgE) Faculty of Medicine, and absolute eosinophilic count. Results: ABPA occurred only in atopic Zagazig University, asthmatics, it was more prevalent with decreased forced expiratory volume Egypt. at the first second (FEV1). Prolonged duration of asthma and steroid dependency were associated with ABPA. AF specific IgE and IgG were higher in the atopic group, they were higher in Aspergillus fumigatus skin Correspondence: prick test positive children than negative ones .Wheal diameter of skin prick Dina Shokry, test had a significant relation to the level of AF IgE titer. Skin prick test Department of positive cases for aspergillus fumigatus was observed in 32% of atopic Pediatrics, Faculty of asthmatic children.
    [Show full text]
  • Final Program for the ATS International Conference Is Available in Printed and Digital Format
    WELCOME TO ATS 2017 • WASHINGTON, DC Welcome to ATS 2017 Welcome to Washington, DC for the 2017 American Thoracic Society International Conference. The conference, which is expected to draw more than 15,000 investigators, educators, and clinicians, is truly the destination for pediatric and adult pulmonary, critical care, and sleep medicine professionals at every level of their careers. The conference is all about learning, networking and connections. Because it engages attendees across many disciplines and continents, the ATS International Conference draws a large, diverse group of participants, a dedicated and collegial community that inspires each of us to make a difference in patients’ lives, now and in the future. By virtue of its size — ATS 2017 features approximately 6,700 original research projects and case reports, 500 sessions, and 800 speakers — participants can attend David Gozal, MD sessions and special events from early morning to the evening. At ATS 2017 there will be something for President everyone. American Thoracic Society Don’t miss the following important events: • Opening Ceremony featuring a keynote presentation by Nobel Laureate James Heckman, PhD, MA, from the Center for the Economics of Human Development at the University of Chicago. • Ninth Annual ATS Foundation Research Program Benefit honoring David M. Center, MD, with the Foundation’s Breathing for Life Award on Saturday. • ATS Diversity Forum will feature Eliseo J. Pérez-Stable, MD, Director, National Institute on Minority Health and Health Disparities at the National Institutes of Health. • Keynote Series highlight state of the art lectures on selected topics in an unopposed format to showcase major discoveries in pulmonary, critical care and sleep medicine.
    [Show full text]
  • The Role of Larygotracheal Reconstruction in the Management of Recurrent Croup in Patients with Subglottic Stenosis
    International Journal of Pediatric Otorhinolaryngology 82 (2016) 78–80 Contents lists available at ScienceDirect International Journal of Pediatric Otorhinolaryngology jo urnal homepage: www.elsevier.com/locate/ijporl The role of larygotracheal reconstruction in the management of recurrent croup in patients with subglottic stenosis a,b,c, a,b a,d,e Bianca Siegel *, Prasad Thottam , Deepak Mehta a Department of Pediatric Otolaryngology, Childrens Hospital of Pittsburgh of UPMC, Pittsburgh, PA, USA b Children’s Hospital of Michigan, Detroit, MI, USA c Wayne State University School of Medicine Department of Otolaryngology, Detroit, MI, USA d Texas Children’s Hospital, Houston, TX, USA e Baylor University School of Medicine Department of Otolaryngology, Houston, TX, USA A R T I C L E I N F O A B S T R A C T Article history: Objectives: To determine the role of laryngotracheal reconstruction for recurrent croup and evaluate Received 16 October 2015 surgical outcomes in this cohort of patients. Received in revised form 4 January 2016 Methods: Retrospective chart review at a tertiary care pediatric hospital. Accepted 6 January 2016 Results: Six patients who underwent laryngotracheal reconstruction (LTR) for recurrent croup with Available online 13 January 2016 underlying subglottic stenosis were identified through a search of our IRB-approved airway database. At the time of diagnostic bronchoscopy, all 6 patients had grade 2 subglottic stenosis. All patients were Keywords: treated for reflux and underwent esophageal biopsies at the time of diagnostic bronchoscopy; 1 patient Laryngotracheal reconstruction had eosinophilic esophagitis which was treated. All patients had a history of at least 3 episodes of croup Recurrent croup in a 1 year period requiring multiple hospital admissions.
    [Show full text]
  • The Pulmonary Manifestations of Left Heart Failure*
    The Pulmonary Manifestations of Left Heart Failure* Brian K. Gehlbach, MD; and Eugene Geppert, MD Determining whether a patient’s symptoms are the result of heart or lung disease requires an understanding of the influence of pulmonary venous hypertension on lung function. Herein, we describe the effects of acute and chronic elevations of pulmonary venous pressure on the mechanical and gas-exchanging properties of the lung. The mechanisms responsible for various symptoms of congestive heart failure are described, and the significance of sleep-disordered breathing in patients with heart disease is considered. While the initial clinical evaluation of patients with dyspnea is imprecise, measurement of B-type natriuretic peptide levels may prove useful in this setting. (CHEST 2004; 125:669–682) Key words: Cheyne-Stokes respiration; congestive heart failure; differential diagnosis; dyspnea; pulmonary edema; respiratory function tests; sleep apnea syndromes Abbreviations: CHF ϭ congestive heart failure; CSR-CSA ϭ Cheyne-Stokes respiration with central sleep apnea; CPAP ϭ continuous positive airway pressure; Dlco ϭ diffusing capacity of the lung for carbon monoxide; DM ϭ membrane conductance; FRC ϭ functional residual capacity; OSA ϭ obstructive sleep apnea; TLC ϭ total lung ϭ ˙ ˙ ϭ capacity; VC capillary volume; Ve/Vco2 ventilatory equivalent for carbon dioxide early 5 million Americans have congestive heart For a detailed review of the pathophysiology of N failure (CHF), with 400,000 new cases diag- high-pressure pulmonary edema, the reader is re- nosed each year.1 Unfortunately, despite the consid- ferred to several excellent recent reviews.2–4 erable progress that has been made in understanding the pathophysiology of pulmonary edema, the pul- monary complications of this condition continue to The Pathophysiology of Pulmonary challenge the bedside clinician.
    [Show full text]
  • Diagnostic Issues in Systemic Lupus Erythematosis
    266 Postgrad Med J 2001;77:266–285 Postgrad Med J: first published as 10.1136/pmj.77.906.268 on 1 April 2001. Downloaded from SELF ASSESSMENT QUESTIONS Diagnostic issues in systemic lupus erythematosis N Sofat, C Higgens Answers on p 274. A 24 year old woman was diagnosed with sys- (4) What other tests (apart from 24 hour urine temic lupus erythematosis (SLE) based on a creatinine clearance) are available to measure few months’ history of a photosensitive skin the glomerular filtration rate? rash, predominantly on her face, arthralgia The patient had a 24 hour urinary protein col- involving both hands and wrists, a positive lection, which showed a 24 hour protein measure- antinuclear antibody (ANA) test and a raised ment of 1.8 g. There was no evidence of cellular antinative double stranded DNA antibody casts on urine microscopy. Her blood results were binding level. She was treated with oral as below (normal values are in parentheses): hydroxychloroquine 400 mg daily and short x Sodium 134 mmol/l (135–145) courses of prednisolone during flare-ups. x Potassium 4.5 mmol/l (3.5–5.0) She was reviewed in clinic for her regular x Urea 7.0 mmol/l (2.5–6.7) follow up appointment when she was found to x Creatinine 173 µmol/l (70–115) be hypertensive on repeated measurements of x Haemoglobin 108 g/l (115–160) her blood pressure, an average value being x White cell count 4.5 × 109/l (4.0–11.0) 150/90 mm Hg. She was also urine dipstick x Platelets 130 × 109/l (150–400) positive for blood and protein.
    [Show full text]